Literature DB >> 15167999

Are there any factors predicting the cure and complication rates of tension-free vaginal tape?

Bülent Cetinel1, Oktay Demirkesen, Bulent Onal, Emre Akkus, Cabir Alan, Gunay Can.   

Abstract

Predictive factors that could possibly affect the cure and complication rates of tension-free vaginal tape (TVT) in the treatment of stress urinary incontinence (SUI) were investigated. Seventy-five consecutive patients with urodynamically proven SUI and who had undergone a TVT operation were evaluated according to a follow-up protocol. Median age was 51.2 (33-69). Thirteen (17%) of the patients had had previous anti-incontinence surgery. Sixteen (21%) patients had complained of pure stress and 59 (79%) of mixed incontinence. Valsalva leak point pressure (VLPP) values had been found to be below 60 cmH(2)O in 36 (48%) and over 60 cmH(2)O in 39 (52%) patients, while detrusor overactivity (DO) had been detected in six (8%) patients during urodynamic evaluation. Local, general, and epidural anesthesia had been performed in 43 (57%), 29 (39%), and three (4%) patients, respectively. Univariate analyses were done using Fisher's exact and Chi-square tests. Multivariate analyses were done using logistic regression test to determine predictive factors affecting cure and complication rates. Mean surgical and hospitalization times were 34.7 min (20-70) and 1.2 days (1-5), respectively. Mean follow-up was 21.6 months (6-38). Cure and improvement rates were 89 and 8%, respectively. Thirty-one complications were observed in 27 (36%) patients. Intraoperative bladder perforation and bleeding occurred in three (4%) and two (3%) patients, respectively. Sixty-six (88%) patients voided spontaneously after TVT while nine (12%) performed clean intermittent catheterization (CIC) for a period of time. Seven of nine patients regained the spontaneous voiding ability within 1 month. The tape was cut in two of these retentive patients and one with severe storage lower urinary tract symptoms (LUTS) either unilaterally or bilaterally. On univariate (Fisher's exact test, p =0.018), and multivariate (Logistic regression, p =0.013) analyses, patient age was the only statistically significant parameter affecting the cure rate, which was significantly lower particularly over 55 years of age. No significant factor predicting the complications was detected. TVT is an effective and safe surgical procedure in the treatment of SUI. In this study age was the only significant predictive factor affecting the cure rate while no significant factor predicting the complications was detected. Cure rate was significantly lower in patients over 55 years of age.

Entities:  

Mesh:

Year:  2004        PMID: 15167999     DOI: 10.1007/s00192-004-1141-0

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  21 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  A three-year postoperative evaluation of tension-free vaginal tape.

Authors:  I Olsson; U Kroon
Journal:  Gynecol Obstet Invest       Date:  1999       Impact factor: 2.031

3.  Evaluation of tension-free vaginal tape procedure. Its safety and efficacy in the treatment of female stress urinary incontinence during the learning phase.

Authors:  T Lebret; P M Lugagne; J M Hervé; P Barré; J L Orsoni; L Yonneau; F Saporta; H Botto
Journal:  Eur Urol       Date:  2001-11       Impact factor: 20.096

4.  Use of intravenous anesthesia for tension-free vaginal tape therapy in elderly women with genuine stress incontinence.

Authors:  Tsia-Shu Lo; Huei-Jean Huang; Chia-Lin Chang; Shu-Yam Wong; Shang-Gwo Horng; Ching-Chung Liang
Journal:  Urology       Date:  2002-03       Impact factor: 2.649

5.  The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.

Authors:  P Abrams; J G Blaivas; S L Stanton; J T Andersen
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

6.  Tension-Free vaginal tape (TVT) in women with mixed urinary incontinence--a long-term follow-up.

Authors:  M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

7.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

8.  A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure.

Authors:  Nina Kuuva; Carl Gustaf Nilsson
Journal:  Acta Obstet Gynecol Scand       Date:  2002-01       Impact factor: 3.636

9.  Polypropylene mesh tape for stress urinary incontinence: complications of urethral erosion and outlet obstruction.

Authors:  Susan D Sweat; Nancy B Itano; J Quentin Clemens; Wade Bushman; Jennifer Gruenenfelder; Edward J McGuire; Deborah J Lightner
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence.

Authors:  U Ulmsten; P Petros
Journal:  Scand J Urol Nephrol       Date:  1995-03
View more
  24 in total

1.  The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors.

Authors:  Harry A M Vervest; Tanya M Bisseling; A Peter M Heintz; Steven E Schraffordt Koops
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-22

2.  Short-term outcomes of vaginal mesh placement among female Medicare beneficiaries.

Authors:  Jennifer T Anger; Aqsa A Khan; Karyn S Eilber; Erin Chong; Stephanie Histed; Ning Wu; Chris L Pashos; J Quentin Clemens
Journal:  Urology       Date:  2014-04       Impact factor: 2.649

Review 3.  Outcomes of Surgery for Stress Urinary Incontinence in the Older Woman.

Authors:  David R Ellington; Elisabeth A Erekson; Holly E Richter
Journal:  Clin Geriatr Med       Date:  2015-07-26       Impact factor: 3.076

4.  Complications of the tension-free vaginal tape procedure for stress urinary incontinence.

Authors:  Ingrid Kristensen; Maysoon Eldoma; Tyler Williamson; Stephen Wood; Tom Mainprize; Sue Ross
Journal:  Int Urogynecol J       Date:  2010-06-25       Impact factor: 2.894

5.  Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients with Stress Urinary Incontinence.

Authors:  Sung-Tae Cho; Hyeong-Cheol Song; Ha-Jong Song; Young-Goo Lee; Ki-Kyung Kim
Journal:  Int Neurourol J       Date:  2010-04-30       Impact factor: 2.835

6.  Prediction of successful voiding immediately after outpatient mid-urethral sling.

Authors:  Kenneth I Barron; Judith A Savageau; Stephen B Young; Lisa C Labin; Abraham N Morse
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-01

7.  Treatment outcome of tension-free vaginal tape in stress urinary incontinence: comparison of intrinsic sphincter deficiency and nonintrinsic sphincter deficiency patients.

Authors:  Sang Wook Bai; Yeo Hwa Jung; Myung Jae Jeon; Da Jung Jung; Sei Kwang Kim; Jae Wook Kim
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-05-03

8.  Irritative symptoms are the main predictor of satisfaction rate in women after transobturator tape procedures.

Authors:  Igor But; Maja Pakiz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-04-01

9.  TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence.

Authors:  F Araco; G Gravante; R Sorge; J Overton; D De Vita; F Sesti; E Piccione
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-01-24

Review 10.  Prolapse and incontinence surgery in older women.

Authors:  Kimberly A Gerten; Alayne D Markland; L Keith Lloyd; Holly E Richter
Journal:  J Urol       Date:  2008-06       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.